The main risks to the outlook for emerging markets this year relate to virus developments and vaccine rollout. The more traditional macro risks are smaller, but one going under the radar in a few large EMs is that fiscal support could be withdrawn too soon, holding back economic recoveries.
Become a client to read more
This is premium content that requires an active Capital Economics subscription to view.
Already have an account?
You may already have access to this premium content as part of a paid subscription.
Sign in to read the content in full or get details of how you can access it
Register for free
Sign up for a free account to gain:
- Unlock additional content
- Register for Capital Economics events
- Receive email updates and economist-curated newsletters
- Request a free trial of our services